Thomas Tötterman

Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas-Long-Term Follow Up

Saellstrom, Sara; Sadeghi, Arian; Eriksson, Emma; Segall, Thomas et al.

Part of Frontiers in Veterinary Science, 2021

• DOI for Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas-Long-Term Follow Up
• Download full text (pdf) of Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas-Long-Term Follow Up

Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients

Schiza, Aglaia; Irenaeus, Sandra; Ortiz-Nieto, Francisco; Loskog, Angelica S. et al.

Part of Scientific Reports, 2019

• DOI for Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients
• Download full text (pdf) of Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients

Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients

Schiza, Aglaia; Wenthe, Jessica; Mangsbo, Sara; Svensson, Emma et al.

Part of Journal of Translational Medicine, 2017

• DOI for Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients
• Download full text (pdf) of Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients

Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients

Irenaeus, Sandra; Schiza, Aglaia; Mangsbo, Sara M.; Wenthe, Jessica et al.

Part of Oncotarget, p. 78573-78587, 2017

• DOI for Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients
• Download full text (pdf) of Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients

Local checkpoint inhibition of CTLA-4 as a monotherapy or in combination with anti-PD1 prevents the growth of murine bladder cancer

van Hooren, Luuk; Sandin, Linda C.; Moskalev, Igor; Ellmark, Peter et al.

Part of European Journal of Immunology, p. 385-393, 2017

• DOI for Local checkpoint inhibition of CTLA-4 as a monotherapy or in combination with anti-PD1 prevents the growth of murine bladder cancer

Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas-Long-Term Follow Up

Saellstrom, Sara; Sadeghi, Arian; Eriksson, Emma; Segall, Thomas et al.

Part of Frontiers in Veterinary Science, 2021

• DOI for Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas-Long-Term Follow Up
• Download full text (pdf) of Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas-Long-Term Follow Up

Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients

Schiza, Aglaia; Irenaeus, Sandra; Ortiz-Nieto, Francisco; Loskog, Angelica S. et al.

Part of Scientific Reports, 2019

• DOI for Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients
• Download full text (pdf) of Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients

Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients

Schiza, Aglaia; Wenthe, Jessica; Mangsbo, Sara; Svensson, Emma et al.

Part of Journal of Translational Medicine, 2017

• DOI for Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients
• Download full text (pdf) of Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients

Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients

Irenaeus, Sandra; Schiza, Aglaia; Mangsbo, Sara M.; Wenthe, Jessica et al.

Part of Oncotarget, p. 78573-78587, 2017

• DOI for Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients
• Download full text (pdf) of Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients

Local checkpoint inhibition of CTLA-4 as a monotherapy or in combination with anti-PD1 prevents the growth of murine bladder cancer

van Hooren, Luuk; Sandin, Linda C.; Moskalev, Igor; Ellmark, Peter et al.

Part of European Journal of Immunology, p. 385-393, 2017

• DOI for Local checkpoint inhibition of CTLA-4 as a monotherapy or in combination with anti-PD1 prevents the growth of murine bladder cancer

Adenovirus-mediated CD40L gene transfer increases teffector/tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients

Schiza, Aglaia; Wenthe, Jessica; Mangsbo, Sara; Eriksson, Emma et al.

Part of Scandinavian Journal of Immunology, p. 337-337, 2017

Donor Derived and BK Virus Positive Urologic Cancers After Renal Transplantation

Hellström, Vivan; Tufveson, Gunnar; Wallgren, AnnaCarin; Loskog, Angelica et al.

Part of American Journal of Transplantation, p. 472-472, 2017

• DOI for Donor Derived and BK Virus Positive Urologic Cancers After Renal Transplantation

Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients

Loskog, Angelica; Maleka, Aglaia; Mangsbo, Sara; Svensson, Emma et al.

Part of British Journal of Cancer, p. 872-880, 2016

• DOI for Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients

Kick-starting the cancer-immunity cycle by targeting CD40

Ellmark, P.; Mangsbo, Sara M.; Furebring, C.; Tötterman, Thomas H. et al.

Part of Oncoimmunology, 2015

• DOI for Kick-starting the cancer-immunity cycle by targeting CD40

The human agonistic CD40 antibody ADC-1013 eradicates bladder tumors and generates T cell dependent tumor immunity

Mangsbo, Sara M; Broos, Sissela; Fletcher, Erika; Veitonmäki, Niina et al.

Part of Clinical Cancer Research, p. 1115-1126, 2015

• DOI for The human agonistic CD40 antibody ADC-1013 eradicates bladder tumors and generates T cell dependent tumor immunity

AdCD40L Immunostimulatory Gene Therapy in Combination with Cyclophosphamide Prolongs 6-Months Survival in a Phase I/II Trial for Malignant Melanoma

Loskog, Angelica; Maleka, Aglaia; Mangsbo, Sara; Svensson, Emma et al.

Part of Molecular Therapy, 2014

• DOI for AdCD40L Immunostimulatory Gene Therapy in Combination with Cyclophosphamide Prolongs 6-Months Survival in a Phase I/II Trial for Malignant Melanoma

Local immunotherapy based on agonistic CD40 antibodies effectively inhibits experimental bladder cancer

Sandin, Linda C.; Tötterman, Thomas H.; Mangsbo, Sara M.

Part of Oncoimmunology, 2014

• DOI for Local immunotherapy based on agonistic CD40 antibodies effectively inhibits experimental bladder cancer

Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo

Sandin, Linda C.; Eriksson, Fredrik; Ellmark, Peter; Loskog, Angelica S. I. et al.

Part of Oncoimmunology, 2014

• DOI for Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo

Locally delivered CD40 agonist antibody accumulates in secondary lymphoid organs and eradicates experimental disseminated bladder cancer

Sandin, Linda; Orlova, Anna; Gustafsson, Erika; Ellmark, Peter et al.

Part of Cancer Immunology Research, p. 80-90, 2014

• DOI for Locally delivered CD40 agonist antibody accumulates in secondary lymphoid organs and eradicates experimental disseminated bladder cancer
• Download full text (pdf) of Locally delivered CD40 agonist antibody accumulates in secondary lymphoid organs and eradicates experimental disseminated bladder cancer

Cytomegalovirus-Specific CD4 and CD8 T Cell Responses in Infants and Children

Lidehäll, Anna Karin; Engman, Mona-Lisa; Sund, Fredrik; Malm, Gunilla et al.

Part of Scandinavian Journal of Immunology, p. 135-143, 2013

• DOI for Cytomegalovirus-Specific CD4 and CD8 T Cell Responses in Infants and Children

Rapid expansion of T cells: Effects of culture and cryopreservation and importance of short-term cell recovery

Sadeghi, Arian; Ullenhag, Gustav; Wagenius, Gunnar; Tötterman, Thomas H et al.

Part of Acta Oncologica, p. 978-986, 2013

• DOI for Rapid expansion of T cells: Effects of culture and cryopreservation and importance of short-term cell recovery

DNA vaccine coding for the rhesus prostate specific antigen delivered by intradermal electroporation in patients with relapsed prostate cancer

Eriksson, Fredrik; Tötterman, Thomas; Maltais, Anna-Karin; Pisa, Pavel et al.

Part of Vaccine, p. 3843-3848, 2013

• DOI for DNA vaccine coding for the rhesus prostate specific antigen delivered by intradermal electroporation in patients with relapsed prostate cancer

T-cell responses after haematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis

Burman, Joachim; Fransson, Moa; Tötterman, Thomas H.; Fagius, Jan et al.

Part of Immunology, p. 211-219, 2013

• DOI for T-cell responses after haematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis

Treatment Efficacy and Immune Stimulation by AdCD40L Gene Therapy of Spontaneous Canine Malignant Melanoma

Westberg, Sara; Sadeghi, Arian; Svensson, Emma; Segall, Thomas et al.

Part of Journal of immunotherapy (1997), p. 350-358, 2013

• DOI for Treatment Efficacy and Immune Stimulation by AdCD40L Gene Therapy of Spontaneous Canine Malignant Melanoma

Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy

Ullenhag, Gustav J; Sadeghi, Arian M; Carlsson, Björn; Ahlström, Håkan et al.

Part of Cancer Immunology and Immunotherapy, p. 725-732, 2012

• DOI for Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy

Response to the letter to the editors from Inge Marie Svane on our manuscript "Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy"

Wagenius, Gunnar; Ullenhag, Gustav J.; Tötterman, Thomas H.

Part of Cancer Immunology and Immunotherapy, p. 749-749, 2012

• DOI for Response to the letter to the editors from Inge Marie Svane on our manuscript "Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy"

Synergistic augmentation of CD40-mediated activation of antigen-presenting cells by amphiphilic poly(gamma-glutamic acid) nanoparticles

Broos, Sissela; Sandin, Linda C.; Apel, Jenny; Tötterman, Thomas H. et al.

Part of Biomaterials, p. 6230-6239, 2012

• DOI for Synergistic augmentation of CD40-mediated activation of antigen-presenting cells by amphiphilic poly(gamma-glutamic acid) nanoparticles

Both CD4(+) FoxP3(+) and CD4(+) FoxP3(-) T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro.

Lindqvist, Camilla; Christiansson, Lisa; Thörn, Ingrid; Mangsbo, Sara et al.

Part of Immunology, p. 296-306, 2011

• DOI for Both CD4(+) FoxP3(+) and CD4(+) FoxP3(-) T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro.

Large-scale bioreactor expansion of tumor-infiltrating lymphocytes

Sadeghi, Arian; Pauler, Linnea; Annerén, Cecilia; Friberg, Andrew et al.

Part of JIM - Journal of Immunological Methods, p. 94-100, 2011

• DOI for Large-scale bioreactor expansion of tumor-infiltrating lymphocytes

Distribution of adoptively transferred porcine T-lymphoblasts tracked by (18)F-2-fluoro-2-deoxy-D-glucose and position emission tomography

Eriksson, Olof; Sadeghi, Arian; Carlsson, Björn; Eich, Torsten et al.

Part of Nuclear Medicine and Biology, p. 827-833, 2011

• DOI for Distribution of adoptively transferred porcine T-lymphoblasts tracked by (18)F-2-fluoro-2-deoxy-D-glucose and position emission tomography

AdCD40L Immunogene Therapy for Bladder Carcinoma: The First Phase I/IIa Trial

Malmström, Per-Uno; Loskog, Angelica S. I.; Lindqvist, Camilla A.; Mangsbo, Sara M. et al.

Part of Clinical Cancer Research, p. 3279-3287, 2010

• DOI for AdCD40L Immunogene Therapy for Bladder Carcinoma: The First Phase I/IIa Trial

CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot study

Sund, Fredrik; Lidehäll, Anna Karin; Claesson, Kerstin; Foss, Aksel et al.

Part of Clinical Transplantation, p. 401-409, 2010

• DOI for CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot study

Resolvin E1 Reduces Proinflammatory Markers in Human Pancreatic Islets in vitro

Lund, T.; Mangsbo, Sara M.; Scholz, H.; Gjorstrup, P. et al.

Part of Experimental and clinical endocrinology & diabetes, p. 237-244, 2010

• DOI for Resolvin E1 Reduces Proinflammatory Markers in Human Pancreatic Islets in vitro

Enhanced tumor eradication by combining CTLA-4 or PD-1 blockade with CpG therapy

Mangsbo, Sara; Sandin, Linda; Anger, Kerstin; Korman, Alan et al.

Part of Journal of immunotherapy (1997), p. 225-235, 2010

• DOI for Enhanced tumor eradication by combining CTLA-4 or PD-1 blockade with CpG therapy

An ex vivo loop system models the toxicity and efficacy of PEGylated and unmodified adenovirus serotype 5 in whole human blood

Danielsson, Angelika; Elgue, Graciela; Nilsson, Berith M.; Nilsson, Bo et al.

Part of Gene Therapy, p. 752-762, 2010

• DOI for An ex vivo loop system models the toxicity and efficacy of PEGylated and unmodified adenovirus serotype 5 in whole human blood

Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas

Leja, Justyna; Essaghir, Ahmed; Essand, Magnus; Wester, Kenneth et al.

Part of Modern Pathology, p. 261-272, 2009

• DOI for Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas

Preclinical evaluation of innate immunity to baculovirus gene therapy vectors in whole human blood

Georgopoulos, Lindsay J.; Elgue, Graciela; Sanchez, Javier; Dussupt, Vincent et al.

Part of Molecular Immunology, p. 2911-2917, 2009

• DOI for Preclinical evaluation of innate immunity to baculovirus gene therapy vectors in whole human blood

High frequency of prostate antigen-directed T cells in cancer patients compared to healthy age-matched individuals

Forsberg, Ole; Carlsson, Björn; Malmström, Per-Uno; Ullenhag, Gustav et al.

Part of The Prostate, p. 70-81, 2009

• DOI for High frequency of prostate antigen-directed T cells in cancer patients compared to healthy age-matched individuals
• Download full text (pdf) of High frequency of prostate antigen-directed T cells in cancer patients compared to healthy age-matched individuals

The T-cell pool is anergized in patients with multiple sclerosis in remission

Fransson, Moa; Liljenfeldt, Lina S.; Fagius, Jan; Tötterman, Thomas et al.

Part of Immunology, p. 92-101, 2009

• DOI for The T-cell pool is anergized in patients with multiple sclerosis in remission

Complement Activation by CpG in a Human Whole Blood Loop System: Mechanisms and Immunomodulatory Effects

Mangsbo, Sara M; Sanchez, Javier; Anger, Kerstin; Lambris, John D et al.

Part of Journal of Immunology, p. 6724-6732, 2009

• DOI for Complement Activation by CpG in a Human Whole Blood Loop System: Mechanisms and Immunomodulatory Effects

Effector T cell analysis of melanoma tumor-infiltrating lymphocyte cultures using HLA-ABC semimatched melanoma cell lines

Carlsson, Björn; Sadeghi, Arian; Bengtsson, Mats; Wagenius, Gunnar et al.

Part of Journal of immunotherapy (1997), p. 633-43, 2008

• DOI for Effector T cell analysis of melanoma tumor-infiltrating lymphocyte cultures using HLA-ABC semimatched melanoma cell lines

CpG Therapy is Superior to BCG in an Orthotopic Bladder Cancer Model and Generates CD4+ T-cell Immunity

Mangsbo, Sara M; Ninalga, Christina; Essand, Magnus; Loskog, Angelica et al.

Part of Journal of immunotherapy (1997), p. 34-42, 2008

• DOI for CpG Therapy is Superior to BCG in an Orthotopic Bladder Cancer Model and Generates CD4+ T-cell Immunity

Strategic use of an adenoviral vector for rapid and efficient ex vivo-generation of cytomegalovirus pp65-reactive cytolytic and helper T cells

Forsberg, Ole; Carlsson, Björn; Tötterman, Thomas H.; Essand, Magnus

Part of British Journal of Haematology, p. 188-199, 2008

• DOI for Strategic use of an adenoviral vector for rapid and efficient ex vivo-generation of cytomegalovirus pp65-reactive cytolytic and helper T cells
• Download full text (pdf) of Strategic use of an adenoviral vector for rapid and efficient ex vivo-generation of cytomegalovirus pp65-reactive cytolytic and helper T cells

CD8(+) T cells against multiple tumor-associated antigens in peripheral blood of midgut carcinoid patients

Vikman, Sofia; Giandomenico, Valeria; Sommaggio, Roberta; Öberg, Kjell et al.

Part of Cancer Immunology and Immunotherapy, p. 399-409, 2008

• DOI for CD8(+) T cells against multiple tumor-associated antigens in peripheral blood of midgut carcinoid patients

Efficient adenovector CD40 ligand immunotherapy of canine malignant melanoma

von Euler, Henrik; Sadeghi, Arian; Carlsson, Björn; Rivera, Patricio et al.

Part of Journal of immunotherapy (1997), p. 377-384, 2008

• DOI for Efficient adenovector CD40 ligand immunotherapy of canine malignant melanoma

CpG oligonucleotides demonstrate increased therapeutic efficacy compared to BCG in an aggressive orthotopic bladder cancer model

Ninalga, Christina; Mangsbo, Sara; Loskog, Angelica; Essand, Magnus et al.

Part of Journal of immunotherapy (1997), p. 34-42, 2008

• DOI for CpG oligonucleotides demonstrate increased therapeutic efficacy compared to BCG in an aggressive orthotopic bladder cancer model

Characterization of human prostate and breast cancer cell lines for experimental T cell-based immunotherapy

Carlsson, Björn; Forsberg, Ole; Bengtsson, Mats; Tötterman, Thomas H. et al.

Part of The Prostate, p. 389-395, 2007

• DOI for Characterization of human prostate and breast cancer cell lines for experimental T cell-based immunotherapy
• Download full text (pdf) of Characterization of human prostate and breast cancer cell lines for experimental T cell-based immunotherapy

Human bladder carcinoma is dominated by T-regulatory cells and Th1 inhibitory cytokines

Loskog, Angelica; Ninalga, Christina; Paul-Wetterberg, Gabriella; de la Torre, Manuel et al.

Part of Journal of Urology, p. 353-358, 2007

• DOI for Human bladder carcinoma is dominated by T-regulatory cells and Th1 inhibitory cytokines

CD40L - a multipotent molecule for tumor therapy

Loskog, Angelica; Tötterman, Thomas

Part of Endocrine, metabolic & immune disorders - drug targets, p. 23-28, 2007

• DOI for CD40L - a multipotent molecule for tumor therapy

An oncolytic conditionally replicating adenovirus for hormone-dependent and hormone-independent prostate cancer

Cheng, Wing-Shing; Dzojic, Helena; Nilsson, Berith; Tötterman, Thomas H. et al.

Part of Cancer Gene Therapy, p. 13-20, 2006

• DOI for An oncolytic conditionally replicating adenovirus for hormone-dependent and hormone-independent prostate cancer

Adenovirus-Mediated CD40 Ligand Therapy Induces Tumor Cell Apoptosis and Systemic Immunity in the TRAMP-C2 Mouse Prostate Cancer Model

Dzojic, Helena; Loskog, Angelica; Tötterman, Thomas H.; Essand, Magnus

Part of The Prostate, p. 831-838, 2006

• DOI for Adenovirus-Mediated CD40 Ligand Therapy Induces Tumor Cell Apoptosis and Systemic Immunity in the TRAMP-C2 Mouse Prostate Cancer Model

Dendritic cells engineered to express CD40L continuously produce IL12 and resist negative signals from Tr1/Th3 dominated tumors

Loskog, Angelica; Ninalga, Christina; Tötterman, Thomas H.

Part of Cancer Immunology and Immunotherapy, p. 588-597, 2006

• DOI for Dendritic cells engineered to express CD40L continuously produce IL12 and resist negative signals from Tr1/Th3 dominated tumors

Optimization of the MB49 mouse bladder cancer model for adenoviral gene therapy

Loskog, Angelica; Ninalga, Christina; Hedlund, Titti; Alimohammadi, Mohammad et al.

Part of Laboratory Animals, p. 384-393, 2005

• DOI for Optimization of the MB49 mouse bladder cancer model for adenoviral gene therapy

Identification and characterization of a novel splicing variant of vesicular monoamine transporter 1

Essand, Magnus; Vikman, Sofia; Grawé, Jan; Gedda, Lars et al.

Part of Journal of Molecular Endocrinology, p. 489-501, 2005

• DOI for Identification and characterization of a novel splicing variant of vesicular monoamine transporter 1

T cell control of primary and latent cytomegalovirus infections in healthy subjects

Lidehäll, Anna Karin; Sund, Fredrik; Lundberg, Tobias; Eriksson, Britt-Marie et al.

Part of Journal of Clinical Immunology, p. 473-481, 2005

• DOI for T cell control of primary and latent cytomegalovirus infections in healthy subjects

Gene expression in midgut carcinoid tumors: potential targets for immunotherapy

Vikman, Sofia; Essand, Magnus; Cunningham, Janet L.; de la Torre, Manuel et al.

Part of Acta Oncologica, p. 32-40, 2005

• DOI for Gene expression in midgut carcinoid tumors: potential targets for immunotherapy

CpG oligonucleotide therapy cures subcutaneous and orthotopic tumors and evokes protective immunity in murine bladder cancer

Ninalga, Christina; Loskog, Angelica; Klevenfeldt, Magdalena; Essand, Magnus et al.

Part of Journal of immunotherapy (1997), p. 20-27, 2005

The immunotherapy of prostate and bladder cancer

Tötterman, Thomas H.; Loskog, Angelica; Essand, Magnus

Part of BJU International, p. 728-735, 2005

• DOI for The immunotherapy of prostate and bladder cancer

AdCD40L gene therapy counteracts T regulatory cells and cures aggressive tumors in an orthotopic bladder cancer model

Loskog, Angelica S.; Fransson, Moa E.; Tötterman, Thomas H.

Part of Clinical Cancer Research, p. 8816-8821, 2005

• DOI for AdCD40L gene therapy counteracts T regulatory cells and cures aggressive tumors in an orthotopic bladder cancer model

A novel TARP-promoter-based adenovirus against hormone-dependent and hormone-refractory prostate cancer

Cheng, Wing-Shing; Kraaij, Robert; Nilsson, Berith; van der Weel, Laura et al.

Part of Molecular Therapy, p. 355-364, 2004

• DOI for A novel TARP-promoter-based adenovirus against hormone-dependent and hormone-refractory prostate cancer

Generation of cytotoxic T lymphocytes specific for the prostate and breast tissue antigen TARP

Carlsson, Björn; Tötterman, Thomas H.; Essand, Magnus

Part of The Prostate, p. 161-170, 2004

• DOI for Generation of cytotoxic T lymphocytes specific for the prostate and breast tissue antigen TARP

Adenovirus CD40 Ligand Gene Therapy Counteracts Immune Escape Mechanisms in the Tumor Microenvironment

Loskog, Angelica; Dzojic, Helena; Vikman, Sofia; Ninalga, Christina et al.

Part of Journal of Immunology, p. 7200-7205, 2004

Enumeration of antigen-specific CD8+ T lymphocytes by single-platform, HLA tetramer-based flow cytometry: a European multicenter evaluation.

Heijnen, Ingmar A F M; Barnett, David; Arroz, Maria J; Barry, Simon M et al.

Part of Cytometry B Clin Cytom, p. 1-13, 2004

Cellular responses to cytomegalovirus in immunosuppressed patients: circulating CD8⁺ T cells recognizing CMVpp65 are present but display functional impairment

Engstrand, Mats; Lidehäll, Anna Karin; Tötterman, Thomas H.; Herrmann, Björn et al.

Part of Clinical and Experimental Immunology, p. 96-104, 2003

• DOI for Cellular responses to cytomegalovirus in immunosuppressed patients: circulating CD8⁺ T cells recognizing CMVpp65 are present but display functional impairment

Human urinary bladder carcinomas express adenovirus attachment and internalization receptors

Loskog, Angelica; Hedlund, Titti; Wester, Kenneth; de la Torre, Manuel et al.

Part of Gene Therapy, p. 547-553, 2002

• DOI for Human urinary bladder carcinomas express adenovirus attachment and internalization receptors

In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154

Loskog, Angelica; Tötterman, Thomas H.; Böhle, Andreas; Brandau, Sven

Part of Cancer Gene Therapy, p. 846-853, 2002

Potent antitumor effects of CD154 transduced tumor cells in experimental bladder cancer

Loskog, Angelica; Björkland, Anna; Brown, Michael P.; Korsgren, Olle et al.

Part of Journal of Urology, p. 1093-1097, 2001

• DOI for Potent antitumor effects of CD154 transduced tumor cells in experimental bladder cancer

Multiple myeloma cells are killed by syndecan-1-directed superantigen-activated T cells

Ragnarsson, Lotten; Strömberg, Thomas; Wijdenes, John; Tötterman, Thomas H. et al.

Part of Cancer Immunology and Immunotherapy, p. 382-390, 2001

• DOI for Multiple myeloma cells are killed by syndecan-1-directed superantigen-activated T cells

Circulating soluble vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in immunocompetent and renal transplant patients:correlation with cytomegalovirus disease and renal function

Eriksson, Britt-Marie; Sjölin, Jan; Claesson, Kerstin; Wirgart, Benita Zweygberg et al.

Part of Scandinavian Journal of Infectious Diseases, p. 350-354, 2001

Characterization of CMVpp65-specific CD8+ T lymphocytes using MHC tetramers in kidney transplant patients and healthy participants

Engstrand, Mats; Tournay, Claire; Peyrat, Marie A.; Eriksson, Britt-Marie et al.

Part of Transplantation, p. 2243-2250, 2000

Roquinimex (Linomide) vs placebo in AML after autologous bone marrow transplantation

Simonsson, Bengt; Tötterman, Thomas H.; Hokland, P.; Lauria, F. et al.

Part of Bone Marrow Transplantation, p. 1121-1127, 2000

Serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) are elevated in advanced stages of non-Hodgkin's lymphomas

Christiansen, Ilse; Sundström, Christer; Kälkner, K.M.; Bring, J. et al.

Part of European Journal of Haematology, p. 202-209, 1999

Staphylococcus aureus Cowan strain 1 activation of B-chronic lymphocytic leukaemia cells augments the response to CD40 stimulation

Söderberg, Ola; Thunberg, Ulf; Weigelt, C.; Christiansen, Ilse et al.

Part of Scandinavian Journal of Immunology, p. 363-370, 1999

• DOI for Staphylococcus aureus Cowan strain 1 activation of B-chronic lymphocytic leukaemia cells augments the response to CD40 stimulation

HpaII polymerase chain reaction restriction fragment length polymorphism in the human CD19 gene on 16p11

Thunberg, Ulf; Gidlöf, C.; Bånghagen, M.; Sällström, J. et al.

Part of Human Heredity, p. 230-231, 1998

• DOI for HpaII polymerase chain reaction restriction fragment length polymorphism in the human CD19 gene on 16p11

Targeted superantigens for immunotherapy of haematopoietic tumours

Tötterman, Thomas H.; Gidlöf, C.; Ragnarsson, L.; Högbom, E. et al.

Part of Vox Sanguinis, p. 483-487, 1998

Serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) are elevated in advanced stage of non-Hodgkin's lymphomas

Christiansen, Ilse; Sundström, Christer; Kälkner, K. M.; Bring, J. et al.

Part of European Journal of Haematology, p. 311-318, 1998

Antibody-directed superantigen-mediated T-cell killing of myeloid leukaemic cell line cells

Gidlöf, Cecilia; Carlson, Barbro; Dohlsten, Mikael; Tötterman, Thomas H.

Part of European Journal of Haematology, p. 233-239, 1998

• DOI for Antibody-directed superantigen-mediated T-cell killing of myeloid leukaemic cell line cells

Soluble vascular cell adhesion molecule-1 (sVCAM-1) is an independent prognostic marker in Hodgkin's disease

Christiansen, Ilse; Sundström, Christer; Enblad, Gunilla; Tötterman, Thomas H.

Part of British Journal of Haematology, p. 701-9, 1998

• DOI for Soluble vascular cell adhesion molecule-1 (sVCAM-1) is an independent prognostic marker in Hodgkin's disease

Elevated serum levels of soluble vascular cell adhesion molecule-1(sVCAM-1) closely reflect tumour burden in chronic B-lymphocytic leukaemia

Christiansen, Ilse; Sundström, Christer; Tötterman, Thomas H.

Part of British Journal of Haematology, p. 1129-1137, 1998

• DOI for Elevated serum levels of soluble vascular cell adhesion molecule-1(sVCAM-1) closely reflect tumour burden in chronic B-lymphocytic leukaemia

A superantigen-antibody fusion protein for T-cellimmunotherapy of human B-lineage malignancies

Gidlöf, Cecilia; Dohlsten, Mikael; Lando, Peter; Kalland, Terje et al.

Part of Blood, p. 2089-2097, 1997

Proteinläkemedel kan nu skräddarsys

Josephson, Staffan; Lind, Peter; Tötterman, Thomas H.

Part of Läkartidningen, p. 2650-2653, 1997

Comparative studies of mitochondrial autoantibodies in sera and bile in primary biliary cirrhosis

Nishio, Akiyosho; Van de Water, Judy; Leung, Patrick S. C.; Joplin, Ruth et al.

Part of Hepatology, p. 1085-1089, 1997

• DOI for Comparative studies of mitochondrial autoantibodies in sera and bile in primary biliary cirrhosis

Mobilization of CD34+ cells by glycosylated and nonglycosylated G-CSF in healthy volunteers: a comparative study

Höglund, M.; Smedmyr, Bengt; Bengtsson, Mats; Tötterman, Thomas H. et al.

Part of European Journal of Haematology, p. 177-183, 1997

• DOI for Mobilization of CD34+ cells by glycosylated and nonglycosylated G-CSF in healthy volunteers: a comparative study

Efficient adenovirus-mediated gene transduction of normal and leukemic hematopoietic cells

Huang, M. R.; Olsson, M.; Kallin, A.; Pettersson, Ulf et al.

Part of Gene Therapy, p. 1093-1099, 1997

Ex vivo PKH26-labelling of lymphocytes for studies of cell migration in vivo

Johnsson, Cecilia; Festin, Roger; Tufveson, Gunnar; Tötterman, Thomas H.

Part of Scandinavian Journal of Immunology, p. 511-514, 1997

• DOI for Ex vivo PKH26-labelling of lymphocytes for studies of cell migration in vivo

Dose-dependent mobilisation of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF

Höglund, M.; Smedmyr, Bengt; Simonsson, Bengt; Tötterman, Thomas H. et al.

Part of Bone Marrow Transplantation, p. 19-27, 1996

Elevated serum levels of soluble ICAM-1 are elevated in non-Hodgkin´s lymphomas and correlate with tumor burden, disease activity and other diagnostic markers

Christiansen, Ilse; Gidlöf, Cecilia; Kälkner, Karl-Mikael; Hagberg, H. et al.

Part of British Journal of Haematology, p. 639-46, 1996

Cytomegalovirus (CMV) DNA amplification from plasma compared with CMV pp65 antigen (ppUL83) detection in leukocytes for early diagnosis of symptomatic CMV infection in kidney transplant patients

Wirgart, Benita Zweygberg; Claesson, Kerstin; Eriksson, Britt-Marie; Brundin, Marianne et al.

Part of Clinical and Diagnostic Virology, p. 99-110, 1996

• DOI for Cytomegalovirus (CMV) DNA amplification from plasma compared with CMV pp65 antigen (ppUL83) detection in leukocytes for early diagnosis of symptomatic CMV infection in kidney transplant patients

A prospective study of rapid methods of detecting cytomegalovirus in the blood of renal transplant recipients in relation to patient and graft survival

Eriksson, Britt-Marie; Wirgart, Benita Zweygberg; Claesson, Kerstin; Tufveson, Gunnar et al.

Part of Clinical Transplantation, p. 494-502, 1996

Antibodies can direct superantigen-mediated T cell killing of chronic B-lymphocytic leukemia cells

Gidlöf, Cecilia; Dohlsten, Mikael; Kalland, Terje; Tötterman, Thomas H.

Part of Leukemia, p. 1534-1542, 1995

Soluble ICAM-1 in Hodgkin´s disease: a promising independent predictive marker for survival

Christiansen, Ilse; Enblad, Gunilla; Kälkner, Karl-Mikael; Gidlöf, Cecilia et al.

Part of Leukemia and Lymphoma, p. 243-51, 1995

Circulating cytokines and granulocyte-derived enzymes during complex heart surgery: A clinical study with special reference to heparin-coating of cardiopulmonary bypass circuits

Borowiec, Jan W.; Hagman, Leif; Tötterman, Thomas H.; Pekna, M. et al.

Part of Scandinavian journal of thoracic and cardiovascular surgery, p. 167-174, 1995

Detection of triple antibody-binding lymphocytes in standard single laser flow cytometry using colloidal gold, fluorescein and phycoerythrin as labels

Festin, Roger; Björklund, Birgitta; Tötterman, Thomas

Part of Journal of immunological methods, p. 23-28, 1987

• DOI for Detection of triple antibody-binding lymphocytes in standard single laser flow cytometry using colloidal gold, fluorescein and phycoerythrin as labels

Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation

Ellmark, Peter; Mangsbo, Sara M.; Furebring, Christina; Norlén, Per et al.

Part of Cancer Immunology and Immunotherapy, p. 1-7, 2017

• DOI for Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation
• Download full text (pdf) of Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation

Genetic engineering - a new era for cancer immunotherapy?

Loskog, Angelica; Tötterman, Thomas H.

Part of Current Cancer Therapy Reviews, p. 194-198, 2007

Immunogold labelling for the single laser FACS analysis of triple antibody-binding cells

Festin, Roger; Tötterman, Thomas

Part of Colloidal gold, Academic Press, 1989

Stamcellstransplantation av maligna lymfom i Uppsala 1986-1994

Enblad, Gunilla; Bengtsson, M.; Berglund, A.; Carlsson, K. et al.

Part of Hygiea, p. 303, 1995